Verity Asset Management, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Verity Asset Management, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,196,042
+29.7%
31,310
+22.5%
0.88%
+28.8%
Q2 2023$922,274
-23.0%
25,569
-18.4%
0.68%
-4.3%
Q1 2023$1,197,371
-20.8%
31,353
+18.0%
0.72%
-44.7%
Q4 2022$1,512,118
-99.9%
26,575
-16.7%
1.29%
-0.6%
Q3 2022$1,260,852,000
+100848.9%
31,888
+1.9%
1.30%
+63.9%
Q1 2022$1,249,000
-13.2%
31,296
-12.6%
0.79%
-6.6%
Q4 2021$1,439,000
+17.0%
35,797
+18.4%
0.85%
+6.6%
Q3 2021$1,230,000
+22.4%
30,241
+36.6%
0.80%
+44.6%
Q2 2021$1,005,000
+24.8%
22,135
+14.6%
0.55%
+14.8%
Q1 2021$805,000
+1.5%
19,310
+4.0%
0.48%
-13.2%
Q4 2020$793,000
+52.8%
18,575
-5.9%
0.55%
+40.0%
Q3 2020$519,000
-12.5%
19,743
-10.7%
0.40%
-27.8%
Q2 2020$593,000
+38.2%
22,106
-7.3%
0.55%
+1.1%
Q1 2020$429,000
-18.6%
23,852
-19.8%
0.54%
+3.0%
Q4 2019$527,000
+10.0%
29,737
-3.7%
0.52%
+4.6%
Q3 2019$479,000
-11.0%
30,871
-1.5%
0.50%
-16.9%
Q2 2019$538,000
+55.0%
31,329
+45.3%
0.60%
+50.6%
Q1 2019$347,000
+16.8%
21,569
+6.2%
0.40%
+0.8%
Q4 2018$297,000
+89.2%
20,313
+24.6%
0.40%
+163.6%
Q4 2014$157,00016,3020.15%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders